Evidence map›Paper›PMID 24941076›Full record

ReviewCritical reviews in immunology2014

Scavenger receptor-A (CD204): a two-edged sword in health and disease.

Jim L Kelley, Tammy R Ozment, Chuanfu Li, John B Schweitzer, David L Williams

Open access · greenAbstract readReview
In one paragraph

Review in Critical reviews in immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 155 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Liver histopathology in dogs with naturally acquiredFrontiers in veterinary science · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Shedding light on macrophage immunotherapy in lung cancer.Journal of cancer research and clinical oncology · 2023
    Review
  14. Review
  15. Article
  16. Article
  17. Innate immune responses in pneumonia.Pneumonia (Nathan Qld.) · 2023
    Review
  18. Article
  19. Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jim L KelleyDepartments of Internal Medicine, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614.
Tammy R OzmentDepartments of Surgery, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614.
Chuanfu LiDepartments of Surgery, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614.
John B SchweitzerDepartments of Pathology, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614.
David L WilliamsDepartments of Surgery, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614.
East Tennessee State University · US

Funding

Role of Toll-Like Receptor Signaling in Cardiac IschemiaR01HL071837 · NHLBI · EAST TENNESSEE STATE UNIVERSITY · PI LI, CHUANFU · 2003 to 2022
$6.1M
Innate Immunity and Cardiovascular Function in SepsisR01GM083016 · NIGMS · EAST TENNESSEE STATE UNIVERSITY · PI LI, CHUANFU, WILLIAMS, DAVID L. · 2009 to 2021
$3.8M
AMELIORATION OF SEPSIS BY MACROPHAGE ACTIVATIONR01GM053522 · NIGMS · EAST TENNESSEE STATE UNIVERSITY · PI WILLIAMS, DAVID L. · 1996 to 2015
$3.4M
NHLBI NIH HHS R01 HL071837NHLBI NIH HHS R01HL071837NIGMS NIH HHS R01 GM053522NIGMS NIH HHS R01 GM083016NIGMS NIH HHS R01GM083016NIGMS NIH HHS R01GM53552
6 · The paper itself

Abstract

Scavenger receptor A (SR-A), also known as the macrophage scavenger receptor and cluster of differentiation 204 (CD204), plays roles in lipid metabolism, atherogenesis, and a number of metabolic processes. However, recent evidence points to important roles for SR-A in inflammation, innate immunity, host defense, sepsis, and ischemic injury. Herein, we review the role of SR-A in inflammation, innate immunity, host defense, sepsis, cardiac and cerebral ischemic injury, Alzheimer's disease, virus recognition and uptake, bone metabolism, and pulmonary injury. Interestingly, SR-A is reported to be host protective in some disease states, but there is also compelling evidence that SR-A plays a role in the pathophysiology of other diseases. These observations of both harmful and beneficial effects of SR-A are discussed here in the framework of inflammation, innate immunity, and endoplasmic reticulum stress.

Indexed as

AnimalsAtherosclerosisHumansImmunity, InnateInflammationIntracellular SpaceOrgan SpecificityScavenger Receptors, Class ASepsisSignal TransductionVirus DiseasesScavenger Receptors, Class A

Identifiers

PMID24941076
PMCPMC4191651
OpenAlexW2020829506

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.